Literature DB >> 63882

Skin manifestations with vasculitis due to co-trimoxazole.

A Wãhlin, N Rosman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 63882     DOI： 10.1016/s0140-6736(76)91960-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Pauci-immune crescentic glomerulonephritis associated with use of trimethoprim-sulfamethoxazole.

Authors:  Shruti S Hegde; Vanesa Bijol; Bertrand L Jaber
Journal:  CEN Case Rep       Date:  2016-06-07

2.  Thrombophlebitis migrans following co-trimoxazole therapy.

Authors:  J Verne-Pignatelli; G P Spickett; A G Dalgleish; A M Denman
Journal:  Postgrad Med J       Date:  1989-01       Impact factor: 2.401

3.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

Review 4.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.